PCA
Personal Capital Advisors Portfolio holdings
AUM
$20.6B
1-Year Return
13.65%
This Quarter Return
+16.93%
1 Year Return
-13.65%
3 Year Return
+17.55%
5 Year Return
+33.04%
10 Year Return
–
AUM
$12.1B
AUM Growth
+$1.97B
(+19%)
Cap. Flow
+$517M
Cap. Flow
% of AUM
4.27%
Top 10 Holdings %
Top 10 Hldgs %
44.83%
Holding
381
New
39
Increased
198
Reduced
111
Closed
19
Top Buys
Top Sells
| 1 |
Schwab US Broad Market ETF
SCHB
|
$55.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
$29.2M |
| 3 |
iShares MSCI KLD 400 Social ETF
DSI
|
$19.3M |
| 4 |
NVIDIA
NVDA
|
$18.9M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
$17.3M |
Sector Composition
| 1 | Technology | 5.6% |
| 2 | Communication Services | 4.14% |
| 3 | Consumer Staples | 3.81% |
| 4 | Materials | 3.76% |
| 5 | Consumer Discretionary | 3.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Altria Group
MO
$112B
| $279K | ﹤0.01% |
7,117
-3,711
| -34% | -$145K |
|
302
iShares MSCI USA Momentum Factor ETF
MTUM
$18.2B
| $278K | ﹤0.01% |
2,123
+40
| +2% | +$5.24K |
|
303
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $274K | ﹤0.01% |
3,359
+619
| +23% | +$50.5K |
|
304
Fiserv
FI
$74B
| $273K | ﹤0.01% |
2,792
-13
| -0.5% | -$1.27K |
|
305
Regeneron Pharmaceuticals
REGN
$60.1B
| $273K | ﹤0.01% |
437
-5
| -1% | -$3.12K |
|
306
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $272K | ﹤0.01% |
3,292
+44
| +1% | +$3.64K |
|
307
Berkshire Hathaway Class A
BRK.A
$1.09T
| $267K | ﹤0.01% |
1
-2
| -67% | -$534K |
|
308
Idexx Laboratories
IDXX
$51.2B
| $265K | ﹤0.01% |
804
-45
| -5% | -$14.8K |
|
309
Cigna
CI
$81.2B
| $263K | ﹤0.01% |
1,399
| – | – |
|
310
Marriott International Class A Common Stock
MAR
$73B
| $262K | ﹤0.01% |
3,054
-11,006
| -78% | -$944K |
|
311
W.R. Berkley
WRB
$27.7B
| $261K | ﹤0.01% |
10,240
-259
| -2% | -$6.6K |
|
312
Wells Fargo
WFC
$262B
| $260K | ﹤0.01% |
10,155
+999
| +11% | +$25.6K |
|
313
Equifax
EFX
$29.6B
| $256K | ﹤0.01% |
+1,488
| New | +$256K |
|
314
Boston Scientific
BSX
$159B
| $255K | ﹤0.01% |
7,249
+99
| +1% | +$3.48K |
|
315
iShares Biotechnology ETF
IBB
$5.68B
| $254K | ﹤0.01% |
+1,861
| New | +$254K |
|
316
Pegasystems
PEGA
$9.21B
| $252K | ﹤0.01% |
+4,984
| New | +$252K |
|
317
iShares Semiconductor ETF
SOXX
$13.5B
| $251K | ﹤0.01% |
+2,784
| New | +$251K |
|
|
318
iShares MSCI KLD 400 Social ETF
DSI
$4.83B
| $250K | ﹤0.01% |
4,242
-327,968
| -99% | -$19.3M |
|
319
Rockwell Automation
ROK
$38.4B
| $250K | ﹤0.01% |
+1,172
| New | +$250K |
|
320
Dominion Energy
D
$50.2B
| $249K | ﹤0.01% |
3,068
-3,385
| -52% | -$275K |
|
321
Mercado Libre
MELI
$123B
| $249K | ﹤0.01% |
+253
| New | +$249K |
|
322
iShares Russell 3000 ETF
IWV
$16.7B
| $247K | ﹤0.01% |
+1,370
| New | +$247K |
|
323
iShares US Technology ETF
IYW
$23.1B
| $246K | ﹤0.01% |
+3,640
| New | +$246K |
|
324
Enterprise Products Partners
EPD
$68.9B
| $245K | ﹤0.01% |
13,504
-1,149
| -8% | -$20.8K |
|
325
Invesco FTSE RAFI US 1000 ETF
PRF
$8.13B
| $236K | ﹤0.01% |
10,900
-2,490
| -19% | -$53.9K |
|